SCHEMBL17792008

SCHEMBL17792008

c1ccc(N(c2cc3ccc4cccc5oc(c2)c3c45)c2ccc3ccc4c(N(c5ccccc5)c5cc6ccc7cccc8oc(c5)c6c78)ccc5ccc2c3c54)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.37
▸ ERBB2 P04626 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ MAOA P21397 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MAOB P27338 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA3 P07451 1/20 0.30
▸ CA4 P22748 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17791954 1.00 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791965 0.94 CYP1A2 (0.36) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791996 0.93 CYP19A1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17792038 0.93 ALDH1A1 (0.43) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17792037 0.93 CYP19A1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791963 0.91 AHR (0.31) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791999 0.91 ALDH1A1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791978 0.91 ERBB2 (0.31) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17791960 0.91 ERBB2 (0.31) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17792016 0.90 RAB9A (0.33) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9793491-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-17 — — US disclosed
US-9793491-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-17 — — US disclosed
US-20160155952-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-02 — — US disclosed
US-20160155952-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160155952-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TMEM109, USE1, TRPC1 CYP1A2 633/4885ERBB2 4581/4885FYN 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback